- LeterMovir
-
- $90.00 / 1kg
-
2024-05-10
- CAS:917389-32-3
- Min. Order: 10kg
- Purity: 0.99
- Supply Ability: 20tons
- LeterMovir
-
- $8.00 / 1kg
-
2024-04-05
- CAS:917389-32-3
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: g-kg-tons, free sample is available
- Letermovir
-
- $0.00 / 25kg
-
2024-03-28
- CAS:917389-32-3
- Min. Order: 25kg
- Purity: 98%
- Supply Ability: Inquiry
|
| | LeterMovir Basic information |
| Product Name: | LeterMovir | | Synonyms: | AIC246;LeterMovir;(4S)-8-Fluoro-3,4-dihydro-2-[4-(3-methoxyphenyl)-1-piperazinyl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4-quinazolineacetic acid;4-Quinazolineacetic acid, 8-fluoro-3,4-dihydro-2-[4-(3-methoxyphenyl)-1-piperazinyl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-, (4S)-;AIC246;AIC 246;AIC-246;CS-2799;Letermovir (AIC246);MK-8828 | | CAS: | 917389-32-3 | | MF: | C29H28F4N4O4 | | MW: | 572.55 | | EINECS: | 200-001-8 | | Product Categories: | API;917389-32-3 | | Mol File: | 917389-32-3.mol |  |
| | LeterMovir Chemical Properties |
| Boiling point | 706.5±70.0 °C(Predicted) | | density | 1.37±0.1 g/cm3(Predicted) | | storage temp. | Sealed in dry,Store in freezer, under -20°C | | solubility | ≥57.3 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O | | form | solid | | pka | 4.00±0.10(Predicted) | | InChIKey | FWYSMLBETOMXAG-QHCPKHFHSA-N | | SMILES | N1C2=C(C=CC=C2F)[C@H](CC(O)=O)N(C2=CC(C(F)(F)F)=CC=C2OC)C=1N1CCN(C2=CC=CC(OC)=C2)CC1 |
| | LeterMovir Usage And Synthesis |
| Uses | Letermovir acts as an orally or i.v administered cytomegalovirus terminus complex inhibitor, antiviral agent, used in the treatment of CMV infection which is prevalent in those with immunocompromised systems. |
| | LeterMovir Preparation Products And Raw materials |
|